MetLife, Inc. $MET Shares Sold by Tokio Marine Asset Management Co. Ltd.

Tokio Marine Asset Management Co. Ltd. lowered its position in shares of MetLife, Inc. (NYSE:METFree Report) by 71.4% in the fourth quarter, Holdings Channel.com reports. The fund owned 17,950 shares of the financial services provider’s stock after selling 44,712 shares during the quarter. Tokio Marine Asset Management Co. Ltd.’s holdings in MetLife were worth $1,417,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. Vermillion & White Wealth Management Group LLC raised its holdings in shares of MetLife by 790.0% during the third quarter. Vermillion & White Wealth Management Group LLC now owns 356 shares of the financial services provider’s stock valued at $29,000 after acquiring an additional 316 shares during the last quarter. Sound Income Strategies LLC raised its holdings in shares of MetLife by 58.9% during the fourth quarter. Sound Income Strategies LLC now owns 383 shares of the financial services provider’s stock valued at $29,000 after acquiring an additional 142 shares during the last quarter. Foster Dykema Cabot & Partners LLC acquired a new position in shares of MetLife during the third quarter valued at approximately $32,000. Albion Financial Group UT acquired a new position in shares of MetLife during the fourth quarter valued at approximately $32,000. Finally, JPL Wealth Management LLC acquired a new position in shares of MetLife during the third quarter valued at approximately $33,000. Institutional investors and hedge funds own 94.99% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have commented on MET. Wells Fargo & Company reduced their target price on MetLife from $93.00 to $90.00 and set an “overweight” rating for the company in a report on Friday, April 10th. Barclays reduced their target price on MetLife from $92.00 to $89.00 and set an “overweight” rating for the company in a report on Wednesday, April 8th. TD Cowen reduced their target price on MetLife from $91.00 to $88.00 and set a “buy” rating for the company in a report on Wednesday, March 11th. Morgan Stanley cut their price target on MetLife from $101.00 to $93.00 and set an “overweight” rating for the company in a report on Tuesday, March 3rd. Finally, Keefe, Bruyette & Woods reaffirmed a “moderate buy” rating and issued a $87.00 price target on shares of MetLife in a report on Thursday, March 26th. One research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $93.38.

View Our Latest Research Report on MetLife

MetLife Price Performance

MET stock opened at $77.71 on Tuesday. The business has a fifty day moving average of $73.16 and a two-hundred day moving average of $76.75. The company has a quick ratio of 0.20, a current ratio of 0.20 and a debt-to-equity ratio of 0.52. The stock has a market cap of $50.67 billion, a price-to-earnings ratio of 16.53, a price-to-earnings-growth ratio of 0.69 and a beta of 0.74. MetLife, Inc. has a 52-week low of $67.33 and a 52-week high of $83.85.

MetLife (NYSE:METGet Free Report) last posted its earnings results on Wednesday, February 4th. The financial services provider reported $2.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.34 by $0.15. The company had revenue of $52.44 billion during the quarter, compared to analysts’ expectations of $31.43 billion. MetLife had a return on equity of 21.81% and a net margin of 4.38%.The firm’s quarterly revenue was up 27.6% compared to the same quarter last year. During the same quarter last year, the firm earned $2.08 earnings per share. As a group, research analysts anticipate that MetLife, Inc. will post 9.85 earnings per share for the current year.

MetLife Company Profile

(Free Report)

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.

Featured Articles

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.